Endocrine and Metabolic Adverse Effects of Psychotropic Medications in Children and Adolescents
- 1 July 2006
- journal article
- review article
- Published by Elsevier in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 45 (7) , 771-791
- https://doi.org/10.1097/01.chi.0000220851.94392.30
Abstract
No abstract availableKeywords
This publication has 213 references indexed in Scilit:
- The Effects of a Family Fitness Program on the Physical Activity and Nutrition Behaviors of Third-Grade ChildrenResearch Quarterly for Exercise and Sport, 2005
- Waist circumference percentiles in nationally representative samples of African-American, European-American, and Mexican-American children and adolescentsThe Journal of Pediatrics, 2004
- Effects of a sweet and a nonsweet lunch on short‐term appetite: differences in female high and low consumers of sweet/low‐energy beveragesJournal of Human Nutrition and Dietetics, 2004
- Atypical Antipsychotic Use in a State Hospital Inpatient Adolescent PopulationJournal of Child and Adolescent Psychopharmacology, 2004
- Public Health and Clinical Recommendations for Physical Activity and Physical FitnessSports Medicine, 2004
- Antipsychotic-Induced HyperprolactinaemiaDrugs, 2004
- Weight Gain Associated with Atypical Antipsychotic Use in Children and AdolescentsPediatric Drugs, 2004
- Switch to quetiapine in antipsychotic agent-related hyperprolactinemiaNeurological Sciences, 2002
- Correlation of Antipsychotic and Prolactin Concentrations in Children and Adolescents Acutely Treated with Haloperidol, Clozapine, or OlanzapineJournal of Child and Adolescent Psychopharmacology, 2002
- Elevated Prolactin in Pediatric Patients on Typical and Atypical AntipsychoticsJournal of Child and Adolescent Psychopharmacology, 1999